Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Flexner

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1B D Walker, C Flexner, K Birch-Limberger, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
Annals of Neurology|August 1, 1994
The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsB G Petty, D R Cornblath, B T Adornato, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytesA Hosmalin, M Clerici, R Houghten, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401J G Gerber, S Rosenkranz, Y Segal, et al.
Annals of Internal Medicine|October 1, 1989
Dextran sulfate is poorly absorbed after oral administrationK J Lorentsen, C W Hendrix, J M Collins, et al.
The Journal of Infectious Diseases|June 1, 1995
High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupB J Dezube, M M Lederman, J G Spritzler, et al.
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
The Journal of Infectious Diseases|December 1, 1994
Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trialsC Flexner, C van der Horst, M A Jacobson, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1B D Walker, C Flexner, K Birch-Limberger, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
Annals of Neurology|August 1, 1994
The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsB G Petty, D R Cornblath, B T Adornato, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytesA Hosmalin, M Clerici, R Houghten, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401J G Gerber, S Rosenkranz, Y Segal, et al.
Annals of Internal Medicine|October 1, 1989
Dextran sulfate is poorly absorbed after oral administrationK J Lorentsen, C W Hendrix, J M Collins, et al.
The Journal of Infectious Diseases|June 1, 1995
High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupB J Dezube, M M Lederman, J G Spritzler, et al.
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
The Journal of Infectious Diseases|December 1, 1994
Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trialsC Flexner, C van der Horst, M A Jacobson, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
Pageof 7